High Performance Medical Plastics Market to be worth $1,242 Million by 2026 : Growing Use in Automotive and Aerospace Industries Drives Growth

 The global high performance medical plastics market size is projected to grow from USD 851 million in 2021 to USD 1,242 million by 2026, at a CAGR of 7.8% during the forecast period 2021 to 2026. The growing use of advanced medical technologies, such as 3D printed implants and customized devices is one of the major factor propelling the growth of the high performance medical plastics market. Growing healthcare infrastructure in emerging economies and increasing instances of chronic diseases such as cancer and heart problems are expected to drive the medical devices market, which in turn, is likely to propel the demand for high performance medical plastics.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=146073142

This growth can be attributed to the shift towards minimally invasive medical procedures, and an increase in demand for advanced medical technologies and devices across the globe. The development in patient-specific implants and 3D printed devices is expected to act as new opportunities for the high performance medical plastics market to grow. However, time consuming regulatory approval process is expected to hinder the market growth during the forecasted period.

Based on application, the high performance medical plastics market has been segmented into medical supplies, medical equipment & tools, prosthesis & impants, drug delivery, theraupetic system, and others. Prosthesis & Implants is the fartest growing application segment of the high performance medical plastics market during the forecast period. High performance medical plastics used in the manufacturing of prosthetics include PEEK, PAI, and PPSU. Implants are mainly used in fixation, fracture plates, and filling purposes. PEEK, PPSU, and fluoropolymers like PTFE are used in the manufacturing of implants. Development of patient specific impants & 3D printing is expected to drive the market growth for this segment during the forecasted period.

Based on type, the high performance medical plastics market has been segmented into fluoropolymers (FP), high performance polyamide (HPPA), polyaryletherketones (PAEK), polyphenylene sulfides (PPS), Polyetherimide (PEI), and others. The PAEK type segment is expected to grow at the fastest CAGR during the forecasted period. The most common type of PAEK used globally in the medical applications is PEEK, as it has superior strength-to-weight ratio. It is lightweight and has self-lubricating properties, good flow properties, and processing properties. It can be filled with carbon fiber, graphite, and molybdenum disulfide to enhance the lubricating properties and mechanical strength further. Increase in adoption of PEEK in medical fields, including cranioplasty, dental implants, interbody fusion, total joint arthroplasty (TJA), and applications to soft-tissue repair is expected to drive the growth of this segment during the forecast period.

Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=146073142

Europe, Asia Pacific and North America, are significant regional markets for high performance medical plastics. Asia Pacific is projected to grow the highest CAGR in the high performance medical plastics market during the forecast period. APAC consists of some vast and rapidly growing economies, such as China, India, Indonesia, Malaysia, Vietnam, Thailand, and others. Across these economies, local governments are reforming regulations in IT integration, advanced materials, and other segments of the healthcare industry to increase the efficiency and efficacy of medical devices and related healthcare services. The major drivers for the medical devices sector in APAC are the change in reforms regarding value-based care in existing systems, ecosystem partnership across value-chain, increasing R&D, and digitalization of the healthcare system. APAC has a huge potential for investment in the healthcare industry, as it comprises emerging economies, such as India, Malaysia, Indonesia, and others. The presence of an integrated value chain and investment capacity is promising for the development of novel applications in the region, ultimately increasing the demand for high performance medical plastics

Solvay SA (Belgium), SABIC (UAE), Mitsubishi Chemical Corporation (Japan), Evonik Industries AG (Germany), Arkema SA (France), Ensinger (Germany), Victrex PLC (UK), Rochling SE & Co. AG (Germany), Raumedic AG (Germany), The Chemours Company (US), DuPont (US), Saint-Gobain Performance Plastics (France), Celanese Corporation (US), Trelleborg (Sweden) and Tekni-Plex (US) are some of the leading players operating in the high performance medical plastics market. These players have adopted the strategies of acquisitions and partnerships to enhance their position in the market.

Solvay SA is the largest company in the global high performance medical plastics market. High performance plastics are a part of the materials business segment of the company. Solvay SA operates through 428 subsidiaries in 64 countries of Europe, North America, Latin America, and Asia-Pacific. The company has 119 operational facilities worldwide. As a global leader in materials, chemicals, and solutions, Solvay brings advancements in planes, cars, batteries, smart and medical devices, and water and air treatment, to solve critical industrial, social, and environmental challenges. Solvay SA, in December 2020 entered into a partnership with PrinterPrezz (US) to develop 3D printing Selective Laser Sintering (SLS) solutions for implants and other medical devices using high performance polymers.

Another important player in the high performance medical plastics market is Evonik Industries AG. The company has vast experience in manufacturing high performance medical plastics and a broad product portfolio, huge production capacity, and sales, logistics, and technical service network. Evonik has a dedicated section for medical plastic division and products like VESTAKEEP, VESTAMID and TRAGOMID care have application in dental applications, body implants and medical devices. Evonik is one of the world leaders in specialty chemicals. Evonik goes far beyond chemistry to create innovative, profitable, and sustainable solutions for customers. The company has done major acquisitions and joint ventures with companies like Durect Corporation and Wynka Silicon for increasing its high performance medical plastics market.

Get 10% Customization on this Report @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=146073142

Comments

Post a Comment

Popular posts from this blog

Building Thermal Insulation Market : Size Analysis by Key Players, End Users, Technologies, Growth & Forecast 2027

  The report  " Building Thermal Insulation Market  by Material (Glasswool, Stonewool, Plastic Foam), Application (Roof Insulation, Floor Insulation, Wall Insulation), Building Type (Residential, Non-Residential) and Region - Global Forecast to 2027",  will grow to USD 35.3 billion by 2027, at a CAGR of 4.7% from USD 28.0 billion in 2022. Browse  in-depth TOC on  "Building Thermal Insulation Market" 313 market data Tables 63 Figures  274 Pages  Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=510 Building thermal insulation is used to reduce the amount of energy required to heat or cool a house and minimize the amount of heat that escapes during the winter and limits the hot summer air to penetrate the house. It is the most cost-effective measure in climates that have a wide range of annual average temperatures. The resistance to heat flow of insulation is measured or rated in terms of its thermal resistance or R-value. The higher the
Read more

Face Mask Market – Business Opportunities and Global Forecast to 2027

The report " Face Mask Market  by Nature (Disposable, Reusable), Material Type, Type (Surgical, Respirator), End-Use, Distribution Channel (Pharmacy & Drug Stores, Supermarket & Hypermarket, Specialty Stores, E-commerce) and Region - Global Forecast to 2027 "The face mask market is projected to grow from USD 25.1 billion in 2022 to USD 3.0 billion by 2027, at a CAGR of -34.5% from 2022 to 2027. The market is projected to witness tremendous growth from 2018 to 2021, followed by a sharp decrease in the years till 2027. Factors contributing to the exponential growth and then decrease during the forecast period in the spread of the COVID-19 globally, and the possible decrease in the spread of the novel coronavirus after the years 2022. Other factors such as the rise in consumer awareness pertaining to the importance of face masks, and the surge in social media marketing to encourage a positive attitude towards wearing masks, are driving the demand for face masks globally.
Read more

Solar Photovoltaic Glass Market Outlook: Emerging Trends and Forecast to 2027

Solar photovoltaic glass market size is projected to reach USD 21.1 billion by 2027 from USD 6.2 billion in 2022 growing at a CAGR of 27.9%. Solar Photovoltaic Glass, also known as solar PV glass or solar glass, refers to a specialized type of glass that is designed to generate electricity from sunlight. It combines the functionality of traditional glass with the energy-producing capabilities of photovoltaic (PV) technology. Solar Photovoltaic Glass is typically made by integrating thin-film solar cells or crystalline silicon solar cells into the glass structure during the manufacturing process. These solar cells are responsible for converting sunlight into electricity through the photovoltaic effect. The glass serves as a protective and supportive layer for the solar cells, allowing them to function effectively while maintaining transparency. The main purpose of Solar Photovoltaic Glass is to capture solar energy and convert it into usable electricity. It finds applications in various
Read more